[144] Legend Biotech Corp SEC Filing

Rhea-AI Filing Summary

Legend Biotech (LEGN) Form 144 disclosure: The filing notifies a proposed sale of 1,370 American Depositary Shares (ADS) valued at $45,210 to be sold via Fidelity Brokerage Services on NASDAQ on 09/24/2025. The shares were acquired 09/20/2025 through restricted stock vesting and were received as compensation. The filing also reports four prior ADS sales by the same person (Ying Huang) during the past three months totaling 40,577 ADS with gross proceeds of $1,566,086.36.

Positive

• Source of shares is clear: the 1,370 ADS were acquired via restricted stock vesting and designated as compensation.
• Filing includes recent sales history: four prior ADS sales totaling 40,577 ADS with gross proceeds of $1,566,086.36, improving transparency.
• Broker and exchange identified: planned sale through Fidelity Brokerage Services on NASDAQ, which supports orderly execution.

Negative

• Insider selling activity: The filer sold 40,577 ADS in the past three months, which is a material volume for transparency considerations.
• Short holding period: The shares to be sold were acquired on 09/20/2025 and proposed for sale on 09/24/2025, indicating a rapid disposition after vesting.

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing recent disposition and a small upcoming sale funded by vested restricted shares.

The Form 144 documents a planned sale of 1,370 ADS (aggregate market value $45,210) executed through a broker on NASDAQ and acquired four days earlier via restricted stock vesting as compensation. The filer previously sold 40,577 ADS in the last three months for aggregate gross proceeds of $1,566,086.36. This pattern appears as scheduled liquidity from equity compensation rather than a single large disposition concentrated in one trade.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 procedures and documents recent insider sales and the source of shares.

The filing provides required notice under Rule 144, identifying the shares' origin (restricted stock vesting) and that the sale will occur through an identified broker. It includes the statutory attestation about knowledge of material nonpublic information. From a governance perspective, the filing is complete for the specific transaction and past-sales disclosure; no additional governance actions or unusual conditions are reported in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1370	45210.00	367298315	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	09/20/2025	Restricted Stock Vesting	Issuer			1370	09/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	06/24/2025	11810	408600.02
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	06/25/2025	12119	408652.68
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	07/23/2025	15291	688722.85
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	09/23/2025	1357	46111.81

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for LEGN disclose?

The filing notifies a proposed sale of 1,370 ADS valued at $45,210, acquired 09/20/2025 via restricted stock vesting and to be sold on 09/24/2025 on NASDAQ.

Who previously sold shares for the account named in the LEGN Form 144?

The filing lists Ying Huang as the seller of ADS on four dates (06/24/2025, 06/25/2025, 07/23/2025, 09/23/2025) totaling 40,577 ADS with gross proceeds of $1,566,086.36.

How were the shares being sold acquired according to the filing?

The 1,370 ADS were acquired on 09/20/2025 through restricted stock vesting from the issuer and were received as compensation.

Through which broker and exchange will the LEGN shares be sold?

The planned sale lists Fidelity Brokerage Services LLC as the broker and NASDAQ as the named securities exchange.

Does the Form 144 include a representation about material nonpublic information?

Yes, the filer signs an attestation representing they do not know any material adverse information about the issuer that has not been publicly disclosed.